We support you as your Legal Representative in Europe according to the EU Clinical Trial Regulation 536/2014 and the former EU Clinical Trial Directive 2001/20/EC Art. 19 (1) and in Switzerland following the Clinical Trials Ordinance.
We act as your Data Representative in accordance with the European General Data Protection Regulation (GDPR) EU 2016/679, if you are a non-European company conducting clinical trials in Europe.
Tailored to your specific needs and expectations, we provide individually adjusted CRO and vendor selection processes to ensure a successful cooperation with your partners.
We implement specific CRO/vendor management oversight and governance strategies and processes to ensure adherence to contract and agreed budget, timelines and quality of your projects.
We provide proactive, risk-based oversight management systems to effectively manage your clinical trial performance, in compliance with relevant ICH-GCP guidelines and ISO standards.
Lumis International – Your clinical gateway to Europe
Lumis International specialises in providing legal representation for clinical trials, for non-European small to mid-sizedbio-pharmaceutical and medical device companies around the globe. We are headquartered in Germany. Find out more
Lumis Life Science Consulting – Your partner for clinical oversight
Our goal is to optimise your drug development process and clinical trials performance using a unique holistic approach from vendor selection to clinical trial oversight management. We act on behalf of our sponsors. Find out more
Contact our experts to find out more!
We look forward to helping you accelerate your clinical development!
-We sat down with Heike Schön our Managing Director to discuss how our clients can remain inspection ready this year, Clinical Trials Information System (CTIS) and to find out what Lumis have in store for 2023! …
-Considering the already high costs involved in conducting clinical trials, the complex regulatory environment, expectations of investors and other stakeholders, the lack of early warning systems of potential clinical trail failures is surprising. In this article we discuss possible reasons for failure and how to better manage these trials. …
-Following the implementation of the new medical device regulations and the revised ISO 14155:2020, the planning and implementation of clinical investigations are a major challenge, especially for small and midsize medical device enterprises (sponsors). Here we walk through how to make the process easier. …